| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Optimal medical therapy with or without PCI for stable coronary disease.
|
N Engl J Med
|
2007
|
25.17
|
|
2
|
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
|
Circulation
|
2006
|
9.83
|
|
3
|
ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2006
|
8.36
|
|
4
|
Effect of PCI on quality of life in patients with stable coronary disease.
|
N Engl J Med
|
2008
|
7.75
|
|
5
|
Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
|
Circulation
|
2008
|
6.30
|
|
6
|
2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2008
|
5.99
|
|
7
|
2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
Circulation
|
2008
|
5.82
|
|
8
|
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina).
|
J Am Coll Cardiol
|
2003
|
3.76
|
|
9
|
ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina).
|
Circulation
|
2003
|
3.16
|
|
10
|
2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 guidelines for the management of patients with chronic stable angina.
|
J Am Coll Cardiol
|
2007
|
2.95
|
|
11
|
Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine).
|
J Am Coll Cardiol
|
2005
|
2.71
|
|
12
|
ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2008
|
1.86
|
|
13
|
Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.
|
Am Heart J
|
2012
|
1.84
|
|
14
|
2007 chronic angina focused update of the ACC/AHA 2002 Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002 Guidelines for the management of patients with chronic stable angina.
|
Circulation
|
2007
|
1.84
|
|
15
|
ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
Circulation
|
2008
|
1.71
|
|
16
|
Impact of metabolic syndrome and diabetes on prognosis and outcomes with early percutaneous coronary intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
|
J Am Coll Cardiol
|
2011
|
1.58
|
|
17
|
Angiographic disease progression and residual risk of cardiovascular events while on optimal medical therapy: observations from the COURAGE Trial.
|
Circ Cardiovasc Interv
|
2011
|
1.56
|
|
18
|
Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
1.43
|
|
19
|
Optimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trial.
|
J Am Coll Cardiol
|
2009
|
1.15
|
|
20
|
Impact of optimal medical therapy with or without percutaneous coronary intervention on long-term cardiovascular end points in patients with stable coronary artery disease (from the COURAGE Trial).
|
Am J Cardiol
|
2009
|
1.06
|
|
21
|
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
|
J Am Coll Cardiol
|
2010
|
0.97
|
|
22
|
Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424.
|
J Nucl Cardiol
|
2006
|
0.90
|
|
23
|
Diagnosis and management of right ventricular myocardial infarction.
|
Curr Probl Cardiol
|
2004
|
0.88
|
|
24
|
The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina.
|
Circ Cardiovasc Qual Outcomes
|
2011
|
0.84
|
|
25
|
Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
|
Am J Cardiol
|
2009
|
0.83
|
|
26
|
Effectiveness of percutaneous coronary intervention in patients with silent myocardial ischemia (post hoc analysis of the COURAGE trial).
|
Am J Cardiol
|
2012
|
0.82
|
|
27
|
Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.
|
Am J Cardiol
|
2009
|
0.81
|
|
28
|
The synergistic effect of heart disease and diabetes on self-management, symptoms, and health status.
|
Heart Lung
|
2006
|
0.78
|
|
29
|
ACC/AHA 2008 guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
|
Catheter Cardiovasc Interv
|
2008
|
0.77
|
|
30
|
Mitral valve prolapse with a late-systolic regurgitant murmur may be associated with significant hemodynamic consequences.
|
Am J Med Sci
|
2009
|
0.77
|
|
31
|
Is Optimal Medical Therapy as Used in the COURAGE Trial Feasible for Widespread Use?
|
Curr Treat Options Cardiovasc Med
|
2011
|
0.76
|
|
32
|
Mitral regurgitation.
|
Curr Probl Cardiol
|
2009
|
0.75
|
|
33
|
Re: One year perspective on COURAGE.
|
Catheter Cardiovasc Interv
|
2009
|
0.75
|
|
34
|
The corrected values for duration and frequency of angina at baseline in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial.
|
Am J Cardiol
|
2007
|
0.75
|
|
35
|
Do major cardiovascular outcomes in patients with stable ischemic heart disease in the clinical outcomes utilizing revascularization and aggressive drug evaluation trial differ by healthcare system?
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.75
|
|
36
|
Current approaches to patients with acute coronary syndromes.
|
Curr Probl Cardiol
|
2002
|
0.75
|
|
37
|
Sophisticated technology is not a substitute for cognitive cardiology.
|
Nat Clin Pract Cardiovasc Med
|
2007
|
0.75
|
|
38
|
Alternative strategies for the management of chronic stable angina.
|
Curr Probl Cardiol
|
2010
|
0.75
|
|
39
|
Cardiac auscultation: rediscovering the lost art. Foreword.
|
Curr Probl Cardiol
|
2008
|
0.75
|